MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1204.07%
Quick Ratio
1204.07%
Cash Ratio
283.59%
Debt to Asset Ratio
8.30%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Cash and cash equivalents
Prepaid expenses and other curre...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Operating lease liabilities, cur...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
37,930
41,886
Marketable securities
119,414
127,061
Prepaid expenses and other current assets
3,701
3,912
Total current assets
161,045
172,859
Property and equipment, net
765
970
Operating lease right-of-use assets
1,883
2,308
Other assets
2,046
2,273
Total assets
165,739
178,410
Accounts payable
2,102
4,189
Accrued expenses
9,008
6,583
Operating lease liabilities, current
2,209
2,205
Other current liabilities
56
66
Total current liabilities
13,375
13,043
Operating lease liabilities, non-current
387
959
Preferred stock
-
0
Total liabilities
13,762
14,002
Common stock
2
13
Additional paid-in capital
818,810
813,734
Accumulated other comprehensive income
100
16
Accumulated deficit
-666,935
-649,355
Total stockholders' equity
151,977
164,408
Total liabilities and stockholders' equity
165,739
178,410
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Marketable securities
$119,414K
Cash and cash
equivalents
$37,930K
Prepaid expenses and
other current assets
$3,701K
Total current assets
$161,045K
Other assets
$2,046K
Operating lease
right-of-use assets
$1,883K
Property and equipment,
net
$765K
Total assets
$165,739K
Total liabilities and
stockholders' equity
$165,739K
Total stockholders'
equity
$151,977K
Total liabilities
$13,762K
Accumulated deficit
-$666,935K
Additional paid-in capital
$818,810K
Total current
liabilities
$13,375K
Operating lease
liabilities, non-current
$387K
Accumulated other
comprehensive income
$100K
Common stock
$2K
Accrued expenses
$9,008K
Operating lease
liabilities, current
$2,209K
Accounts payable
$2,102K
Other current
liabilities
$56K
Buy us a coffee
RAPT Therapeutics, Inc. (RAPT)
RAPT Therapeutics, Inc. (RAPT)